NCT05726721 Profiling the Dynamic of Binge Eating Disorder (PRODY-BED)
| NCT ID | NCT05726721 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Aarhus University Hospital |
| Condition | Binge-Eating Disorder |
| Study Type | OBSERVATIONAL |
| Enrollment | 180 participants |
| Start Date | 2023-07-03 |
| Primary Completion | 2027-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 180 participants in total. It began in 2023-07-03 with a primary completion date of 2027-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to explore if different and specific profiles can be identified in adults with binge eating disorder (BED) depending on their additional eating pathology, emotion regulation and executive functions. The main questions it aims to answer are: * Is there different and specific subgroups of patients with BED according to baseline profiles in emotion regulation, executive function and additional eating pathology (including restriction, chaotic eating, grazing and eating on external cues)? * Are subgroups of individuals with BED (based on identified profiles) associated with outcome at end of treatment and follow-up? * What is the trajectories in remission rates of specific symptom dimensions (eating disorder pathology, emotion regulation, executive function, and depressive symptoms) in individuals with BED and is there specific trajectory profiles in these dimensions? * Is early changes in specific symptom dimensions (eating pathology, emotion regulation, executive function, or depression) associated with outcome of BED? Participants will be asked to fill in questionnaires before treatment as usual, 10 weeks into treatment, at end of treatment and at 6- and 12-month follow-up.
Eligibility Criteria
Inclusion Criteria: * Age 18+, * diagnosed with Binge eating Disorder, * and offered treatment at on of the inclusion sites. Exclusion Criteria: * Severe psychiatric comorbidity (e.g. psychosis, severe developmental disorder, severe cogntive impairement)
Contact & Investigator
Loa Clausen, PhD
PRINCIPAL INVESTIGATOR
Aarhus University Hospital, Psychiatry
Frequently Asked Questions
Who can join the NCT05726721 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Binge-Eating Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05726721 currently recruiting?
Yes, NCT05726721 is actively recruiting participants. Contact the research team at loaclaus@rm.dk for enrollment information.
Where is the NCT05726721 trial being conducted?
This trial is being conducted at Aarhus, Denmark, Aalborg, Denmark, Copenhagen NV, Denmark.
Who is sponsoring the NCT05726721 clinical trial?
NCT05726721 is sponsored by Aarhus University Hospital. The principal investigator is Loa Clausen, PhD at Aarhus University Hospital, Psychiatry. The trial plans to enroll 180 participants.